Related Experiment Video
Updated: Jan 21, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy genetic test reports: A qualitative study of patient understanding of uninformative
Brooke M Nightingale1, Shelly R Hovick2, Pamela Brock1
1Division of Human Genetics, The Ohio State University, Columbus, Ohio.
Insights
Patients with hypertrophic cardiomyopathy (HCM) often misunderstand genetic test results. Current reports fail to clarify genetic risks and familial implications, highlighting a need for improved patient-facing communication tools.
Area of Science:
- Genetics
- Cardiology
- Medical Communication
Background:
- Patients with hypertrophic cardiomyopathy (HCM) may misinterpret uninformative genetic testing results.
- This misinterpretation can lead to a false sense of security regarding genetic etiology and familial risk.
Purpose of the Study:
- To examine patient comprehension of uninformative genetic test results and laboratory reports.
- To identify patient suggestions for improving genetic test reports and communication of familial risk.
Main Methods:
- A qualitative study involving semi-structured interviews with fifteen participants diagnosed with HCM.
- Participants had undergone genetic testing and received their laboratory report.
Main Results:
- Most participants reported only partially reading or understanding the genetic test report, often relying on provider explanations.
- Evidence of misunderstanding was present, with many finding specific report aspects unhelpful for understanding results or communicating risk to relatives.
- Participants desired a supplemental report detailing a personalized clinical 'action plan' for patient and family implications.
Conclusions:
- Current laboratory genetic test reports and physician-directed letters are insufficient for patient comprehension of results and familial implications in HCM.
- There is a significant need for patient-directed educational supplements, such as an 'action plan,' to improve understanding and facilitate risk communication.
Abstract:
Studies have shown that patients with hypertrophic cardiomyopathy (HCM) may misinterpret the meaning of uninformative genetic testing results to mean that a genetic etiology and family members' risk is ruled out. We hypothesized that poor comprehension of the laboratory genetic test report may contribute to this misunderstanding. We conducted a qualitative study to examine patient understanding of uninformative laboratory results and reports and elicit suggestions for an improved report. Fifteen participants with HCM were interviewed after undergoing genetic testing and receiving their report. While all patients read the report, most participants reported only partially reading it. Most reported not understanding the report at all or only partially understanding it because a provider explained it to them. Some participants said that the report was helpful for understanding their result, but there was evidence of misunderstanding; most participants stated that specific aspects of the report were unhelpful. While most of our participants communicated risk with relatives, none said that the report helped with the communication. Most participants did not recall or find the accompanying physician-directed result letter useful for their understanding or familial communication. Many participants expressed need for a supplemental report that illustrates a personalized clinical 'action plan' that could summarize clinical and familial implications of the result for the patient and their family. We conclude that laboratory reports and physician-directed result letters did not help participants understand their results or their familial implications. Our results suggest opportunities for research to explore the utility of a patient-directed result supplement to improve patient comprehension of genetic test results and outline clinical recommendations via a patient action plan.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
What is Genetic Engineering?
What is Population Genetics?
Genetics of Speciation
Animal Mitochondrial Genetics
Types of Genetic Transfer Between Organisms

